TGY2IT
ALNY icon

Timothy G. Youngquist 2020 Irrevocable Trust’s Alnylam Pharmaceuticals ALNY Stock Holding History

Timothy G. Youngquist 2020 Irrevocable Trust’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-147
Closed -$48.6K – 136
2026
Q1 		$48.6K Buy
+147
New +$50K 0.02% 222

Other funds holding ALNY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Timothy G. Youngquist 2020 Irrevocable Trust's ALNY Position: Q2 2026 in Review

Timothy G. Youngquist 2020 Irrevocable Trust sold out of Alnylam Pharmaceuticals (ALNY) in Q2 2026, closing a stake of 147 shares — an estimated $48.6K sold.

Timothy G. Youngquist 2020 Irrevocable Trust first reported a position in ALNY in Q1 2026 and held it in 1 quarter. The position peaked at $48.6K in Q1 2026. 365 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Timothy G. Youngquist 2020 Irrevocable Trust reported no remaining Alnylam Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Timothy G. Youngquist 2020 Irrevocable Trust sold 147 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $48.6K.
  • Timothy G. Youngquist 2020 Irrevocable Trust first reported a position in Alnylam Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Timothy G. Youngquist 2020 Irrevocable Trust's Alnylam Pharmaceuticals position peaked at $48.6K in Q1 2026.
  • 365 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Timothy G. Youngquist 2020 Irrevocable Trust's 13F filing for Q2 2026, filed 7 Aug 2026.